REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,761,000 | +24.5% | 17,500 | +75.0% | 0.62% | +9.9% |
| Q2 2021 | $1,415,000 | +1.4% | 10,000 | -28.6% | 0.56% | +12.3% |
| Q1 2021 | $1,396,000 | -41.5% | 14,000 | -8.5% | 0.50% | -27.1% |
| Q2 2020 | $2,387,000 | -29.6% | 15,300 | -34.9% | 0.69% | -58.0% |
| Q1 2020 | $3,392,000 | -56.3% | 23,500 | -38.2% | 1.64% | -14.6% |
| Q4 2019 | $7,768,000 | +115.0% | 38,000 | -15.6% | 1.92% | -26.2% |
| Q3 2019 | $3,613,000 | – | 45,000 | – | 2.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |